Bausch Health Companies (BHC) Operating Margin (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Operating Margin came in at 37.64% in Q1 2026, down 4986.0% year-on-year from 0.77% in Q1 2025, and down 322.02% quarter-over-quarter from 16.95% in Q4 2025.
Bausch Health Companies (BHC) Operating Margin (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Operating Margin across 18 years of filings, most recently posting 37.64% for Q1 2026.
- Operating Margin for Q1 2026 came in at 37.64%, down 4986.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.57% (down 1026.0% YoY), and the FY2025 annual result was 17.66%, up 160.0% from the prior year.
- Operating Margin came in at 37.64% for Q1 2026 at Bausch Health Companies, down from 16.95% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 23.09% in Q3 2025 to a low of 37.64% in Q1 2026.
- The 5-year median for Operating Margin is 13.05% (2024), against an average of 9.63%.
- Across the five-year window, Operating Margin jumped 2579 bps in 2023 and plunged 4986 bps in 2026, its largest moves.
- Bausch Health Companies' Operating Margin stood at 10.76% in 2022, then jumped by 240 bps to 15.03% in 2023, then soared by 45 bps to 21.81% in 2024, then fell by 22 bps to 16.95% in 2025, then plunged by 322 bps to 37.64% in 2026.
- The last three Operating Margin figures came in at 37.64% (Q1 2026), 16.95% (Q4 2025), and 23.09% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -122.23% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -12.88% |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | -37.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.64% |
| Dec 31, 2025 | 16.95% |
| Sep 30, 2025 | 23.09% |
| Jun 30, 2025 | 17.55% |
| Mar 31, 2025 | 12.22% |
| Dec 31, 2024 | 21.81% |
| Sep 30, 2024 | 12.67% |
| Jun 30, 2024 | 16.19% |
| Mar 31, 2024 | 13.05% |
| Dec 31, 2023 | 15.03% |
| Sep 30, 2023 | 0.63% |
| Jun 30, 2023 | 19.01% |
| Mar 31, 2023 | 9.00% |
| Dec 31, 2022 | -10.76% |
| Sep 30, 2022 | 11.93% |
| Jun 30, 2022 | 8.19% |
| Mar 31, 2022 | 14.86% |
| Dec 31, 2021 | 5.07% |
| Sep 30, 2021 | 27.19% |
| Jun 30, 2021 | -12.86% |